Description
Lecarnita Solution for Injections 1g/5 ml. 5 ml. Ampoules №5
Ingredients:
Each 5 ml ampoule contains 1g of Levocarnitine.
Mechanism of Action:
Levocarnitine, the active ingredient in Lecarnita solution, facilitates the transport of long-chain fatty acids into the mitochondria for beta-oxidation. This process is essential for energy production, particularly in tissues like skeletal and cardiac muscles.
Pharmacological Properties:
Lecarnita solution replenishes the deficient levels of carnitine in the body, correcting metabolic imbalances and supporting energy metabolism. Levocarnitine also exhibits antioxidant properties, contributing to cellular health and function.
Indications for Use:
Lecarnita solution is indicated for the treatment of primary and secondary carnitine deficiency, which can manifest as muscle weakness, fatigue, and metabolic disturbances. It is also beneficial in managing certain inborn errors of metabolism.
Contraindications:
Avoid using Lecarnita solution if you have a known hypersensitivity to Levocarnitine or any other components of the product. Consult your physician before initiating therapy if you have renal impairment or other significant medical conditions.
Side Effects:
Common side effects of Lecarnita solution may include gastrointestinal disturbances like nausea or diarrhea. In rare cases, allergic reactions such as rash or itching may occur. Report any unexpected or severe adverse effects to your healthcare provider.
Usage Instructions:
The typical dosage regimen involves administering 1-2 ampoules daily, either via intramuscular injection or slow intravenous infusion. Your healthcare provider will determine the most appropriate route and frequency of administration based on your individual needs.
Benefits Compared to Analogues:
Lecarnita solution offers the advantage of precise dosing and rapid replenishment of carnitine levels compared to oral formulations. Its parenteral administration ensures efficient absorption and bioavailability, making it particularly beneficial in acute settings or when oral intake is compromised.
Suitable Patient Groups:
Lecarnita solution can be safely used in various patient populations, including children and the elderly, under appropriate medical supervision. Dosing adjustments may be necessary in individuals with hepatic or renal insufficiency to prevent accumulation of metabolites.
Storage Conditions and Shelf Life:
- Store the ampoules in a cool, dry place away from direct sunlight to maintain stability and potency.
- Keep the product out of reach of children to prevent accidental ingestion or misuse.
- Discard any solution that appears discolored or contains particulate matter, as it may indicate degradation or contamination.
Packaging Description:
Lecarnita solution is supplied in individual 5 ml ampoules for single-dose administration. The packaging is designed to ensure sterility and protection of the product from external factors that could compromise its quality.
